Literature DB >> 33408783

Retina as a window to cerebral dysfunction following studies with circRNA signature during neurodegeneration.

Qin Jiang1,2, Dong-Yuan Su3, Zhen-Zhen Wang1,2, Chang Liu1,2, Ya-Nan Sun4, Hong Cheng5, Xiu-Miao Li1, Biao Yan4,6.   

Abstract

Ischemia-induced cerebral injury is a major cause of dementia or death worldwide. The pre-diagnosis is still challenging due to the retarded symptoms. The retina is regarded as the extension of cerebral tissue. Circular RNAs have emerged as the crucial regulators in gene regulatory network and disease progression. However, it is still unknown whether circRNAs can be used as the common regulators and diagnostic markers for cerebral neurodegeneration and retinal neurodegeneration.
Methods: C57BL/6J mice were subjected to transient middle cerebral artery occlusion and circRNA microarray profiling was performed to identify neurodegeneration-related circRNAs. Quantitative reverse-transcription PCR (qRT-PCR) assays were performed to verify circRNA expression pattern. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed to determine the biologic modules and signaling pathway. TTC staining, Nissl's staining, and immunofluorescence staining assays were performed to investigate the role of circRNA in cerebral neurodegeneration and retinal neurodegeneration in vivo. MTT assay, Propidium iodide (PI)/Calcein-AM staining, and Rhodamine 123 assays were performed to investigate the role of circRNA in neuronal injury in vitro. Bioinformatics, RIP, and luciferase activity assays were performed to determine the regulatory mechanism of circRNA in neurodegeneration.
Results: 217 differentially expressed circRNAs were identified between ischemic cerebral tissues and normal controls. Among them, cGLIS3 was shown as the common regulator of cerebral neurodegeneration and retinal neurodegeneration. cGLIS3 silencing alleviated ischemia-induced retinal neurodegeneration and MCAO-induced cerebral neurodegeneration in vivo. cGLIS3 silencing protected against OGD/R-induced RGC injury in vitro. The circulating levels of cGLIS3 were significantly increased in the patients with ischemic stroke compared to healthy subjects. cGLIS3 levels were also increased in the aqueous humor of the patients with retinal vein occlusion. cGLIS3 regulated neuronal cell injury by acting as miR-203 sponge and its level was controlled by EIF4A3. Conclusions: This study provides molecular evidence that the retina is window of the brain from circRNA perspective. cGLIS3 is a common regulator and diagnostic marker of cerebral neurodegeneration and retinal neurodegeneration. © The author(s).

Entities:  

Keywords:  Circular RNAs; Ischemia; MCAO; OGD/R; retinal neurodegeneration

Year:  2021        PMID: 33408783      PMCID: PMC7778582          DOI: 10.7150/thno.51550

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  7 in total

Review 1.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

2.  A stepwise-targeting strategy for the treatment of cerebral ischemic stroke.

Authors:  Jingbo Hu; Xueying Tan; Dongwei Wang; Yixuan Li; Hongze Liang; Jiejun Peng; Fengyan Li; Quan Zhou; Peiwu Geng; Shuanghu Wang; Yue Yu; Jin Liu
Journal:  J Nanobiotechnology       Date:  2021-11-17       Impact factor: 9.429

3.  Impact of CircRNAs on Ischemic Stroke.

Authors:  Miaomiao Liu; Xiaolin Liu; Maorong Zhou; Shao Guo; Kai Sun
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

4.  Profile and Functional Prediction of Plasma Exosome-Derived CircRNAs From Acute Ischemic Stroke Patients.

Authors:  Jie Yang; Junli Hao; Yapeng Lin; Yijia Guo; Ke Liao; Min Yang; Hang Cheng; Ming Yang; Kejie Chen
Journal:  Front Genet       Date:  2022-03-14       Impact factor: 4.599

5.  Silencing of circular RNA‑ZYG11B exerts a neuroprotective effect against retinal neurodegeneration.

Authors:  Cong Ma; Mu-Di Yao; Xiao-Yan Han; Ze-Hui Shi; Biao Yan; Jian-Ling Du
Journal:  Int J Mol Med       Date:  2022-06-22       Impact factor: 5.314

6.  Common methods in mitochondrial research (Review).

Authors:  Yiyuan Yin; Haitao Shen
Journal:  Int J Mol Med       Date:  2022-08-25       Impact factor: 5.314

7.  Conditional deletion of MAD2B in forebrain neurons enhances hippocampus-dependent learning and memory in mice.

Authors:  Li Cheng; Yanfang Su; Kaining Zhi; Yaru Xie; Chun Zhang; Xianfang Meng
Journal:  Front Cell Neurosci       Date:  2022-09-23       Impact factor: 6.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.